Table 2. Comparison of dGEMRIC, T2, T1, T2* and T1ρ values in the tibia, femur, and defect for the ASC, BMSC, defect and US groups.
| MRI techniques | Groups | Tibia | Femur | Defect |
|---|---|---|---|---|
| dGEMRIC, ms | ASC | 521.36±119.08 | 484.85±161.14 | 461.70±175.88 |
| BMSC | 533.46±77.51 | 443.23±105.52 | 432.03±170.03 | |
| Defect | 616.53±141.57 | 610.01±190.82 | 404.84±64.2 | |
| US | 599.00±227.09 | 647.55±237.60 | 649.81±295.73 | |
| T2, ms | ASC | 40.68±4.96 | 43.48±3.18 | 39.42±4.75 |
| BMSC | 42.11±4.30 | 45.54±4.41 | 38.79±3.51 | |
| Defect | 36.71±2.15 | 40.92±4.36 | 44.24±2.75 | |
| US | 40.85±2.44 | 43.12±1.97 | 40.95±2.76 | |
| T1, ms | ASC | 901.62±103.67 | 839.15±38.97 | 857.51±102.81 |
| BMSC | 930.69±134.36 | 847.16±107.18 | 925.47±106.36 | |
| Defect | 840.91±119.78 | 873.94±100.29 | 887.30±116.17 | |
| US | 875.45±69.8 | 899.64±63.83 | 1041.12±113.71 | |
| T2*, ms | ASC | 17.18±4.21 | 18.14±3.26 | 17.28±3.32 |
| BMSC | 17.95±4.44 | 18.65±2.62 | 15.21±2.79 | |
| Defect | 20.40±3.87 | 21.88±3.79 | 19.63±4.57 | |
| US | 18.75±2.39 | 21.52±2.73 | 14.79±2.48 | |
| T1ρ, ms | ASC | 75.57±8.01 | 88.85±9.80 | 83.15±9.19 |
| BMSC | 78.65±7.23 | 98.54±7.85 | 75.61±13.07 | |
| Defect | 92.31±11.31 | 89.25±19.29 | 88.9±24.79 | |
| US | 82.54±14.52 | 91.06±7.28 | 94.65±11.61 | |
| ΔT1, ms | ASC | 380.26±145.64 | 354.30±174.50 | 395.81±230.61 |
| BMSC | 397.22±164.95 | 403.93±76.61 | 493.44±203.46 | |
| Defect | 224.38±237.20 | 263.94±192.48 | 482.43±117.97 | |
| US | 276.46±192.06 | 252.08±223.23 | 391.32±381.68 |
Data are presented as mean ± standard deviation. dGEMRIC, delayed gadolinium-enhanced magnetic resonance imaging of cartilage; ASC, adipose-derived stromal cell; BMSC, bone marrow-derived mesenchymal stromal cell; US, unseeded scaffold; MRI, magnetic resonance imaging.